S. 1040 aims to alter the Federal Trade Commission Act to stop pharmaceutical companies from engaging in "product hopping." This practice involves making minor changes to a drug, like reformulating it, to extend patent protections and delay generic versions from entering the...
Simple Explanation
S. 1040 is a proposed law that wants to stop medicine companies from slightly changing their medicines just to keep other companies from making less expensive versions. It tells the rules so everyone plays fair and doesn’t cheat by removing old medicines to make people buy new ones.